Medical Aesthetics Market overview:
In a recent research report by Market Research Community, the Medical Aesthetics Market is expected to surpass USD 27.54 Billion by the year 2028, from USD 13.52 Billion in 2021.
By region, Asia-Pacific Medical Aesthetics Market is growing at a significant rate. Growing medical aesthetics procedures awareness, rising medical tourism, and aggressive marketing by leading companies in the Asia Pacific region are factors contributing to the growth of the medical aesthetics market.
The procedure type segment is categorized into invasive and non-invasive. The invasive is expected to grow at a significant rate. The growth can be attributed to the increasing aesthetic procedures such as breast augmentation, nose reshaping, and liposuction.
Medical aesthetics is a procedure that focuses on the treatment of scars, moles, excess fat, wrinkles, skin discoloration, and others. It includes both surgical and non-surgical procedures such as plastic surgery, unwanted hair removal, and others.
The study is consolidated into major segments and further into sub-segments, such as by Procedure Type (Invasive, Non-Invasive), by Product type (Botox, Dermal Filler, Liposuction, Skin Tightening, Breast Implant), End-Use (Hospitals, Clinics, Medical Spa), to forecast the Medical Aesthetics Market Size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
The market is projected to grow at a significant pace reaching a CAGR of approximately 10.7%, over the forecast period of 2022–2028, despite a considerable fall in product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
Lastly, the report includes a regional analysis and country analysis with the latest trends, along with the major key players including AbbVie, Cynosure, Evolus Inc., Revance Galderma, Lumenis, Solta Medical, Syneron Candela, Alma Laser.
Contact:
Market Research Community
